You are here

Efficacy & Safety of REFACTO AF in Prophylaxis Treatment

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Severe Hemophilia A
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
1-18 year
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Male subjects with severe hemophilia A (FVIII:C

2. Age from 1 to 18 years

3. Previously untreated patients (PUPs) or previously treated patients (PTPs) with factor
VIII

4. No previous history of FVIII inhibitors

5. Legally authorized representatives of pediatric patients agree to provide written
informed consent form

6. Patients who are scheduled by their hematologist to initiate prophylaxis with ReFacto
AF or to continue previously initiated prophylaxis with ReFacto AF, including patients
who are switching from prophylaxis with another FVIII product to ReFacto AF.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Subject has known hypersensitivity to the active substance or any of the excipients.

2. Subject has known allergic reaction to hamster proteins

3. Presence of any bleeding disorder in addition to hemophilia A.

4. Treatment with any investigational agent or device within the past 30 days.

5. Any other contraindications according to Summary of Product Characteristics

6. Unsuitable to participate in study for any other reason as assessed by investigator

NCT02718677
Pfizer
Not yet recruiting
Efficacy & Safety of REFACTO AF in Prophylaxis Treatment

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Severe Hemophilia A
NCT02718677
Males

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now